服务热线
15339069646服务热线
15339069646| Item | Cat. No. | Application | Isotype |
| Anti-INHBA mAbs [Garetosmab Biosimilar] (MABL-4745) | MABL-4745 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDL1/CD274 mAbs [Garivulimab Biosimilar] (MABL-4746) | MABL-4746 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-MUC1/PEM/EMA mAbs [Gatipotuzumab Biosimilar] (MABL-4747) | MABL-4747 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-CD52 mAbs [Gatralimab Biosimilar] (MABL-4748) | MABL-4748 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-Influenza A HA mAbs [Gedivumab Biosimilar] (MABL-4749) | MABL-4749 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-C5;ALB mAbs [Gefurulimab Biosimilar] (MABL-4750) | MABL-4750 | ELISA, FACS, Functional assay, in vivo binding | na;na, na;na |
| Anti-SIGLEC3/CD33/p67 mAbs [Gemtuzumab Biosimilar] (MABL-4751) | MABL-4751 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-PDCD1/CD279/PD1 mAbs [Geptanolimab Biosimilar] (MABL-4752) | MABL-4752 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-IL1B mAbs [Gevokizumab Biosimilar] (MABL-4753) | MABL-4753 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-CALCA and CALCB mAbs [Fremanezumab Biosimilar] (MABL-4725) | MABL-4725 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-Fel d 1 mAbs [Freneslerbart Biosimilar] (MABL-4726) | MABL-4726 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-TGFB mAbs [Fresolimumab Biosimilar] (MABL-4727) | MABL-4727 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-CD40LG/CD154 mAbs [Frexalimab Biosimilar] (MABL-4728) | MABL-4728 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-PCSK9 mAbs [Frovocimab Biosimilar] (MABL-4729) | MABL-4729 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
| Anti-NGFB mAbs [Frunevetmab Biosimilar] (MABL-4730) | MABL-4730 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-NGFB mAbs [Fulranumab Biosimilar] (MABL-4731) | MABL-4731 | ELISA, FACS, Functional assay, in vivo binding | G2, Kappa |
| Anti-CTLA4/CD152 mAbs [Futermestotug Biosimilar] (MABL-4732) | MABL-4732 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-EGFR/ERBB1/HER1 mAbs [Futuximab Biosimilar] (MABL-4733) | MABL-4733 | ELISA, FACS, Functional assay, in vivo binding | G1, Kappa |
| Anti-F4+ ETEC (Veterinary Application) mAbs [Gacovetug Biosimilar] (MABL-4734) | MABL-4734 | ELISA, FACS, Functional assay, in vivo binding | A1, na |
| Anti-CALCA and CALCB mAbs [Galcanezumab Biosimilar] (MABL-4735) | MABL-4735 | ELISA, FACS, Functional assay, in vivo binding | G4, Kappa |
联系我们
Copyright © 2012-2029 西安迈博睿（Mabioway）生物科技有限公司 版权所有
地址：陕西省西安市浐灞生态区广运潭大道南段4555号长安大学科技园4号楼A单元2层
电话：15339069646 邮箱：info@mabioway.cn